Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...
In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...
Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA ...
Labcorp will start testing for monkeypox, doubling testing capacity nationwide. Labcorp will start testing for monkeypox, doubling testing capacity nationwide. Beginning Wednesday, Labcorp will test ...
Enhanced Liver Fibrosis (ELF™) Test Gauges Likelihood of Disease Progression; Expands Labcorp’s Testing Options for Nonalcoholic Fatty Liver Disease The ELF test provides a numeric score to people ...
This electron microscopic (EM) image depicted a monkeypox virion, obtained from a clinical sample associated with the 2003 prairie dog outbreak. It was a thin section image from of a human skin sample ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially ...
Liquid biopsy test for cancer patients enables oncologists to identify targeted therapies and improve care BURLINGTON, N.C., May 31, 2023 /PRNewswire/ -- Labcorp (LH) (NYSE: LH), a leading global life ...
Laboratory Corporation of America Holdings LH, known as LabCorp, recently launched the Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Labcorp will begin testing for monkeypox using the CDC's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results